These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 25843117)
1. Chitosan Oligosaccharides Attenuate Atherosclerosis and Decrease Non-HDL in ApoE-/- Mice. Yu Y; Luo T; Liu S; Song G; Han J; Wang Y; Yao S; Feng L; Qin S J Atheroscler Thromb; 2015; 22(9):926-41. PubMed ID: 25843117 [TBL] [Abstract][Full Text] [Related]
2. Hepatic Overexpression of Endothelial Lipase Lowers High-Density Lipoprotein but Maintains Reverse Cholesterol Transport in Mice: Role of Scavenger Receptor Class B Type I/ATP-Binding Cassette Transporter A1-Dependent Pathways. Takiguchi S; Ayaori M; Yakushiji E; Nishida T; Nakaya K; Sasaki M; Iizuka M; Uto-Kondo H; Terao Y; Yogo M; Komatsu T; Ogura M; Ikewaki K Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1454-1467. PubMed ID: 29748333 [TBL] [Abstract][Full Text] [Related]
3. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans. Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454 [TBL] [Abstract][Full Text] [Related]
4. Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet. Song G; Liu J; Zhao Z; Yu Y; Tian H; Yao S; Li G; Qin S Lipids Health Dis; 2011 Jan; 10():8. PubMed ID: 21241519 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Zhang W; Yancey PG; Su YR; Babaev VR; Zhang Y; Fazio S; Linton MF Circulation; 2003 Nov; 108(18):2258-63. PubMed ID: 14581413 [TBL] [Abstract][Full Text] [Related]
6. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. Wang X; Collins HL; Ranalletta M; Fuki IV; Billheimer JT; Rothblat GH; Tall AR; Rader DJ J Clin Invest; 2007 Aug; 117(8):2216-24. PubMed ID: 17657311 [TBL] [Abstract][Full Text] [Related]
7. The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL/6 and apoE-knockout mice. Joyce CW; Amar MJ; Lambert G; Vaisman BL; Paigen B; Najib-Fruchart J; Hoyt RF; Neufeld ED; Remaley AT; Fredrickson DS; Brewer HB; Santamarina-Fojo S Proc Natl Acad Sci U S A; 2002 Jan; 99(1):407-12. PubMed ID: 11752403 [TBL] [Abstract][Full Text] [Related]
8. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174 [TBL] [Abstract][Full Text] [Related]
9. Chitosan oligosaccharides promote reverse cholesterol transport and expression of scavenger receptor BI and CYP7A1 in mice. Zong C; Yu Y; Song G; Luo T; Li L; Wang X; Qin S Exp Biol Med (Maywood); 2012 Feb; 237(2):194-200. PubMed ID: 22302708 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Zhao JF; Ching LC; Huang YC; Chen CY; Chiang AN; Kou YR; Shyue SK; Lee TS Mol Nutr Food Res; 2012 May; 56(5):691-701. PubMed ID: 22648616 [TBL] [Abstract][Full Text] [Related]
11. Foam cells in atherosclerosis. Yu XH; Fu YC; Zhang DW; Yin K; Tang CK Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937 [TBL] [Abstract][Full Text] [Related]
12. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice. Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213 [TBL] [Abstract][Full Text] [Related]
13. A novel small molecule liver X receptor transcriptional regulator, nagilactone B, suppresses atherosclerosis in apoE-deficient mice. Gui Y; Yao S; Yan H; Hu L; Yu C; Gao F; Xi C; Li H; Ye Y; Wang Y Cardiovasc Res; 2016 Oct; 112(1):502-14. PubMed ID: 27460841 [TBL] [Abstract][Full Text] [Related]
14. Probucol-Oxidized Products, Spiroquinone and Diphenoquinone, Promote Reverse Cholesterol Transport in Mice. Yakushiji E; Ayaori M; Nishida T; Shiotani K; Takiguchi S; Nakaya K; Uto-Kondo H; Ogura M; Sasaki M; Yogo M; Komatsu T; Lu R; Yokoyama S; Ikewaki K Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):591-7. PubMed ID: 26848156 [TBL] [Abstract][Full Text] [Related]
15. Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis. Feng Y; Lievens J; Jacobs F; Hoekstra M; Van Craeyveld E; Gordts SC; Snoeys J; De Geest B Cardiovasc Res; 2010 Nov; 88(2):376-85. PubMed ID: 20562425 [TBL] [Abstract][Full Text] [Related]
16. Knockdown expression and hepatic deficiency reveal an atheroprotective role for SR-BI in liver and peripheral tissues. Huby T; Doucet C; Dachet C; Ouzilleau B; Ueda Y; Afzal V; Rubin E; Chapman MJ; Lesnik P J Clin Invest; 2006 Oct; 116(10):2767-76. PubMed ID: 16964311 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post-transcriptional repression of scavenger receptor class B type I. Ren K; Zhu X; Zheng Z; Mo ZC; Peng XS; Zeng YZ; Ou HX; Zhang QH; Qi HZ; Zhao GJ; Yi GH Atherosclerosis; 2018 Mar; 270():57-67. PubMed ID: 29407889 [TBL] [Abstract][Full Text] [Related]
18. Enhanced foam cell formation, atherosclerotic lesion development, and inflammation by combined deletion of ABCA1 and SR-BI in Bone marrow-derived cells in LDL receptor knockout mice on western-type diet. Zhao Y; Pennings M; Hildebrand RB; Ye D; Calpe-Berdiel L; Out R; Kjerrulf M; Hurt-Camejo E; Groen AK; Hoekstra M; Jessup W; Chimini G; Van Berkel TJ; Van Eck M Circ Res; 2010 Dec; 107(12):e20-31. PubMed ID: 21071707 [TBL] [Abstract][Full Text] [Related]
19. Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport. Yamamoto S; Tanigawa H; Li X; Komaru Y; Billheimer JT; Rader DJ Circulation; 2011 Sep; 124(12):1382-90. PubMed ID: 21859969 [TBL] [Abstract][Full Text] [Related]
20. Cholesterol reduction and atherosclerosis inhibition by bezafibrate in low-density lipoprotein receptor knockout mice. Inaba T; Yagyu H; Itabashi N; Tazoe F; Fujita N; Nagashima S; Okada K; Okazaki M; Furukawa Y; Ishibashi S Hypertens Res; 2008 May; 31(5):999-1005. PubMed ID: 18712055 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]